These recommendations could open the floodgates for a potential multibillion-dollar peptide industry in the US, where peptides are already a buzzword among wellness influencers, Hollywood, and the manosphere
Starting a new medication can feel both hopeful and uncertain, and your first day on retatrutide is no exception
The team focuses on education, safety, and achievable progress so every patient can feel confident in their results
If your situation needs tailored advice, contact the RNA Law team
GLP-1 is a USD150175bn global market opportunity over the coming decade
Our goal is simple: ensure that every patient who can benefit from our medicines has the opportunity to access them, wherever they choose to receive care. Hims & Hers will offer the following Novo Nordisk GLP-1 medications: 0.5 mg Ozempic injection 1 mg Ozempic injection 2 mg Ozempic injection 1.5 mg Wegovy tablets 4 mg Wegovy tablets 9 mg Wegovy tablets 25 mg Wegovy tablets 0.25 mg Wegovy injection 0.5 mg Wegovy injection 1 mg Wegovy injection 1.7 mg Wegovy injection 2.4 mg Wegovy injection Novo Nordisk took legal action against Hims & Hers in February of this year, 2 claiming that the telehealth company was mass marketing unapproved versions of Novos GLP-1 offerings